{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:51Z","timestamp":1787032851905,"version":"build-2736575974"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,27]]},"DOI":"10.7759\/cureus.70313","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T07:29:53Z","timestamp":1727422193000},"source":"Crossref","is-referenced-by-count":2,"title":["The Nexus of Aging and Substance Use: A Scoping Review of Therapeutic Modalities for Geriatric Substance Use Disorders"],"prefix":"10.7759","author":[{"given":"Noah","family":"Leton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Substance use and substance use disorders. (2024). Accessed. 10 June 2024: https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2024\/additional-considerations\/substance-use."},{"key":"ref2","unstructured":"Substance use in older adults drug facts. (2020). Accessed. 10 June 2024: https:\/\/nida.nih.gov\/publications\/drugfacts\/substance-use-in-older-adults-drugfacts."},{"key":"ref3","unstructured":"What is substance use disorder?. (2024). Accessed. 10 June 2024: https:\/\/www.psychiatry.org\/patients-families\/addiction-substance-use-disorders\/what-is-a-substance-use-disorder."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40501-023-00291-9","article-title":"Substance use disorders in the geriatric population: a review and synthesis of the literature of a growing problem in a growing population","author":"Lin J","year":"2023","unstructured":"Lin J, Arnovitz M, Kotbi N, Francois D. Substance use disorders in the geriatric population: a review and synthesis of the literature of a growing problem in a growing population. Curr Treat Options Psychiatry. 2023, 1-20. 10.1007\/s40501-023-00291-9","journal-title":"Curr Treat Options Psychiatry"},{"key":"ref5","unstructured":"Diagnostic and statistical manual of mental disorders. DSM-5-TR \/ American Psychiatric Association. (2016). Accessed: 10 June 2024: https:\/\/www.mredscircleoftrust.com\/storage\/app\/media\/DSM%205%20TR.pdf."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-43099-7_10","article-title":"Pharmacokinetic and pharmacodynamic considerations in elderly population","author":"Mukker JK","year":"2016","unstructured":"Mukker JK, Singh RS, Derendorf H. Pharmacokinetic and pharmacodynamic considerations in elderly population. Developing Drug Products in an Aging Society. Stegemann S (ed): Springer, Cham; 2016. 26:139-51. 10.1007\/978-3-319-43099-7_10"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.92122","article-title":"Elderly and polypharmacy: physiological and cognitive changes","author":"Rodrigues AD","year":"2021","unstructured":"Rodrigues AD, Herdeiro MT, Figueiras A, Coutinho P, Roque F. Elderly and polypharmacy: physiological and cognitive changes. Frailty in the Elderly - Understanding and Managing Complexity. Palermo S (ed): IntechOpen, London; 2021. 10.5772\/intechopen.92122"},{"key":"ref8","unstructured":"Pharmacokinetics in older adults. (2021). Accessed. 12 June 2024: https:\/\/www.msdmanuals.com\/en-au\/professional\/geriatrics\/drug-therapy-in-older-adults\/pharmacokinetics-in-older-adults."},{"key":"ref9","unstructured":"Social isolation, loneliness in older people pose health risks. (2019). Accessed. 12 June 2024: https:\/\/www.nia.nih.gov\/news\/social-isolation-loneliness-older-people-pose-health-risks."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-15967-3","article-title":"The state of loneliness and social isolation research: current knowledge and future directions","volume":"23","author":"Taylor HO","year":"2023","unstructured":"Taylor HO, Cudjoe TK, Bu F, Lim MH. The state of loneliness and social isolation research: current knowledge and future directions. BMC Public Health. 2023, 23:1049. 10.1186\/s12889-023-15967-3","journal-title":"BMC Public Health"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-023-04229-x","article-title":"Barriers and facilitators of older adults for professional mental health help-seeking: a systematic review","volume":"23","author":"Elshaikh U","year":"2023","unstructured":"Elshaikh U, Sheik R, Saeed RK, Chivese T, Alsayed Hassan D. Barriers and facilitators of older adults for professional mental health help-seeking: a systematic review. BMC Geriatr. 2023, 23:516. 10.1186\/s12877-023-04229-x","journal-title":"BMC Geriatr"},{"key":"ref12","article-title":"Barriers facing older adults with substance use disorders in post-acute care settings","volume":"44","author":"Lau-Ng R","year":"2021","unstructured":"Lau-Ng R, Day H, Alford DP. Barriers facing older adults with substance use disorders in post-acute care settings. Generations. 2021, 44:1-10.","journal-title":"Generations"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-017-0104-7","article-title":"Strategies to facilitate integrated care for people with alcohol and other drug problems: a systematic review","volume":"12","author":"Savic M","year":"2017","unstructured":"Savic M, Best D, Manning V, Lubman DI. Strategies to facilitate integrated care for people with alcohol and other drug problems: a systematic review. Subst Abuse Treat Prev Policy. 2017, 12:19. 10.1186\/s13011-017-0104-7","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"ref14","unstructured":"Substance use challenges in older adults. Accessed. 14 June 2024: https:\/\/www.thenationalcouncil.org\/substance-use-challenges-in-older-adults\/."},{"key":"ref15","unstructured":"Guide to substance abuse in older adults. risks, warning signs, and treatments. (2024). Accessed: 14 June 2024: https:\/\/www.seniorliving.org\/research\/substance-abuse-seniors\/."},{"key":"ref16","unstructured":"Get the facts on economic security for seniors. (2024). Accessed. 14 June 2024: https:\/\/www.ncoa.org\/article\/get-the-facts-on-economic-security-for-seniors\/."},{"key":"ref17","unstructured":"Medicare\u2019s affordability problem. a look at the cost burdens faced by older enrollees. (2023). Accessed: 15 June 2024: https:\/\/www.commonwealthfund.org\/publications\/issue-briefs\/2023\/sep\/medicare-affordability-problem-cost-burdens-biennial."},{"key":"ref18","unstructured":"Alcohol and the aging brain. (2018). Accessed. 15 June 2024: https:\/\/niaaa.scienceblog.com\/103\/alcohol-and-the-aging-brain\/."},{"key":"ref19","unstructured":"Alcohol's effects on the body. (2024). Accessed. 15 June 2024: https:\/\/www.niaaa.nih.gov\/alcohols-effects-health\/alcohols-effects-body."},{"key":"ref20","unstructured":"Alcohol use in older adults. (2023). Accessed. 15 June 2024: https:\/\/www.camh.ca\/en\/health-info\/guides-and-publications\/alcohol-use-in-older-adults."},{"key":"ref21","unstructured":"Facts about aging and alcohol. (2022). Accessed. 16 June 2024: https:\/\/www.nia.nih.gov\/health\/alcohol-misuse-or-alcohol-use-disorder\/facts-about-aging-and-alcohol."},{"key":"ref22","unstructured":"Brain health in over 50s deteriorated more rapidly during the pandemic, study finds. (2023). Accessed. 16 June 2024: https:\/\/www.sciencedaily.com\/releases\/2023\/11\/231102135209.htm."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-01015-9","article-title":"Suicidal thoughts and behaviors among untreated illicit substance users: a population-based study","volume":"21","author":"Shiraly R","year":"2024","unstructured":"Shiraly R, Jazayeri SA, Seifaei A, Jeihooni AK, Griffiths MD. Suicidal thoughts and behaviors among untreated illicit substance users: a population-based study. Harm Reduct J. 2024, 21:96. 10.1186\/s12954-024-01015-9","journal-title":"Harm Reduct J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.37665","article-title":"Follow-up survey of US adult reports of mental health, substance use, and suicidal ideation during the COVID-19 pandemic, September 2020","volume":"4","author":"Czeisler M\u00c9","year":"2021","unstructured":"Czeisler M\u00c9, Lane RI, Wiley JF, Czeisler CA, Howard ME, Rajaratnam SM. Follow-up survey of US adult reports of mental health, substance use, and suicidal ideation during the COVID-19 pandemic, September 2020. JAMA Netw Open. 2021, 4:e2037665. 10.1001\/jamanetworkopen.2020.37665","journal-title":"JAMA Netw Open"},{"key":"ref25","unstructured":"Addiction and health. (2011). Accessed. 16 June 2024: https:\/\/nida.nih.gov\/publications\/drugs-brains-behavior-science-addiction\/addiction-health."},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2020.06.010","article-title":"Applying the infectious diseases literature to people who inject drugs","volume":"34","author":"Serota DP","year":"2020","unstructured":"Serota DP, Chueng TA, Schechter MC. Applying the infectious diseases literature to people who inject drugs. Infect Dis Clin North Am. 2020, 34:539-58. 10.1016\/j.idc.2020.06.010","journal-title":"Infect Dis Clin North Am"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.09.024","article-title":"Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis","volume":"129","author":"Rosenthal ES","year":"2016","unstructured":"Rosenthal ES, Karchmer AW, Theisen-Toupal J, Castillo RA, Rowley CF. Suboptimal addiction interventions for patients hospitalized with injection drug use-associated infective endocarditis. Am J Med. 2016, 129:481-5. 10.1016\/j.amjmed.2015.09.024","journal-title":"Am J Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-023-10412-y","article-title":"Models of good practice to enhance infectious disease care cascades among people who inject drugs: a qualitative study of interventions implemented in European settings","volume":"23","author":"Horv\u00e1th I","year":"2023","unstructured":"Horv\u00e1th I, M\u00e5rdh O, Schwarz T. Models of good practice to enhance infectious disease care cascades among people who inject drugs: a qualitative study of interventions implemented in European settings. BMC Health Serv Res. 2023, 23:1352. 10.1186\/s12913-023-10412-y","journal-title":"BMC Health Serv Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-84834-7_1","article-title":"Drug use and mental health: comorbidity between substance use and psychiatric disorders","author":"Sullivan MA","year":"2022","unstructured":"Sullivan MA . Drug use and mental health: comorbidity between substance use and psychiatric disorders. Substance and Non-substance Related Addictions. Akerele E (ed): Springer, Cham; 2022. 3-17. 10.1007\/978-3-030-84834-7_1"},{"key":"ref30","unstructured":"The connection between substance use disorders and mental illness. (2022). Accessed. 17 June 2024: https:\/\/nida.nih.gov\/publications\/research-reports\/common-comorbidities-substance-use-disorders\/part-1-connection-bet...."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-022-03466-w","article-title":"International depiction of the cost of functional independence limitations among older adults living in the community: a systematic review and cost-of-impairment study","volume":"22","author":"Falck RS","year":"2022","unstructured":"Falck RS, Percival AG, Tai D, Davis JC. International depiction of the cost of functional independence limitations among older adults living in the community: a systematic review and cost-of-impairment study. BMC Geriatr. 2022, 22:815. 10.1186\/s12877-022-03466-w","journal-title":"BMC Geriatr"},{"key":"ref32","unstructured":"Fast facts. health and economic costs of chronic conditions. (2024). Accessed: 17 July 2024: https:\/\/www.cdc.gov\/chronic-disease\/data-research\/facts-stats\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/chronicdisease\/about...."},{"key":"ref33","unstructured":"U.S. and global approaches to financing long-term care. understanding the patchwork. (2023). Accessed: 17 June 2024: https:\/\/www.commonwealthfund.org\/publications\/issue-briefs\/2023\/feb\/us-global-financing-long-term-care-patchwork."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7015a1","article-title":"State-level economic costs of opioid use disorder and fatal opioid overdose \u2014 United States, 2017","volume":"70","author":"Luo F","year":"2021","unstructured":"Luo F, Li M, Florence C. State-level economic costs of opioid use disorder and fatal opioid overdose \u2014 United States, 2017. MMWR Morb Mortal Wkly Rep. 2021, 70:541-6. 10.15585\/mmwr.mm7015a1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref35","unstructured":"What are the current costs and outcomes related to mental health and substance use disorders?. (2017). Accessed. 17 June 2024: https:\/\/www.healthsystemtracker.org\/chart-collection\/current-costs-outcomes-related-mental-health-substance-abuse-dis...."},{"key":"ref36","unstructured":"How much do medicare beneficiaries spend out of pocket on health care?. (2019). Accessed. 17 June 2024: https:\/\/www.kff.org\/medicare\/issue-brief\/how-much-do-medicare-beneficiaries-spend-out-of-pocket-on-health-care\/."},{"key":"ref37","unstructured":"SUD treatment in Medicaid. variation by service type, demographics, states and spending. (2024). Accessed: 17 June 2024: https:\/\/www.kff.org\/mental-health\/issue-brief\/sud-treatment-in-medicaid-variation-by-service-type-demographics-states...."},{"key":"ref38","unstructured":"Treating substance use disorder in older adults. (2020). Accessed. 19 June 2024: https:\/\/store.samhsa.gov\/sites\/default\/files\/tip-26-pep20-02-01-011.pdf."},{"key":"ref39","unstructured":"Alcohol Use Disorders Identification Test (AUDIT). (2024). Accessed. 19 June 2024: https:\/\/www.samhsa.gov\/resource\/dbhis\/alcohol-use-disorders-identification-test-audit."},{"key":"ref40","unstructured":"Geriatric Depression Scale (GDS). (2020). Accessed. 19 June 2024: https:\/\/www.apa.org\/pi\/about\/publications\/caregivers\/practice-settings\/assessment\/tools\/geriatric-depression."},{"key":"ref41","unstructured":"Drug management programs. (2023). Accessed. 19 June 2024: https:\/\/www.commonwealthcarealliance.org\/ma\/providers\/training-and-programs\/drug-management-program\/."},{"key":"ref42","unstructured":"Addressing substance use disorders in geriatric population. (2023). Accessed. 19 June 2024: https:\/\/www.nyp.org\/advances\/article\/geriatrics\/addressing-substance-use-disorders-in-geriatric-population."},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/hsw\/hls023","article-title":"Combined motivational interviewing and cognitive-behavioral therapy with older adult drug and alcohol abusers","volume":"37","author":"Cooper L","year":"2012","unstructured":"Cooper L. Combined motivational interviewing and cognitive-behavioral therapy with older adult drug and alcohol abusers. Health Soc Work. 2012, 37:173-9. 10.1093\/hsw\/hls023","journal-title":"Health Soc Work"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.psc.2010.04.012","article-title":"Cognitive behavioral therapy for substance use disorders","volume":"33","author":"McHugh RK","year":"2010","unstructured":"McHugh RK, Hearon BA, Otto MW. Cognitive behavioral therapy for substance use disorders. Psychiatr Clin North Am. 2010, 33:511-25. 10.1016\/j.psc.2010.04.012","journal-title":"Psychiatr Clin North Am"},{"key":"ref45","unstructured":"Medication-assisted treatment (\u201cMAT\u201d) for opioid use disorder. a NACo opioid solutions strategy brief. (2022). Accessed: 20 June 2024: https:\/\/www.naco.org\/resource\/osc-mat."},{"key":"ref46","unstructured":"How effective are medications to treat opioid use disorder?. (2021). Accessed. 20 June 2024: https:\/\/nida.nih.gov\/publications\/research-reports\/medications-to-treat-opioid-addiction\/efficacy-medications-opioid-...."},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03260-y","article-title":"The effectiveness, implementation, and experiences of peer support approaches for mental health: a systematic umbrella review","volume":"22","author":"Cooper RE","year":"2024","unstructured":"Cooper RE, Saunders KR, Greenburgh A, et al.. The effectiveness, implementation, and experiences of peer support approaches for mental health: a systematic umbrella review. BMC Med. 2024, 22:72. 10.1186\/s12916-024-03260-y","journal-title":"BMC Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.31128\/AJGP-02-22-6331","article-title":"Lifestyle interventions in the management of substance use disorder","volume":"51","author":"Naren T","year":"2022","unstructured":"Naren T, Cook J, Armstrong F, Manger S. Lifestyle interventions in the management of substance use disorder. Aust J Gen Pract. 2022, 51:560-4. 10.31128\/AJGP-02-22-6331","journal-title":"Aust J Gen Pract"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110728","article-title":"Impact of physical exercise on substance use disorders: a meta-analysis","volume":"9","author":"Wang D","year":"2014","unstructured":"Wang D, Wang Y, Wang Y, Li R, Zhou C. Impact of physical exercise on substance use disorders: a meta-analysis. PLoS One. 2014, 9:e110728. 10.1371\/journal.pone.0110728","journal-title":"PLoS One"},{"key":"ref50","unstructured":"What are the treatments for comorbid substance use disorder and mental health conditions?. (2021). Accessed. 20 June 2024: https:\/\/nida.nih.gov\/publications\/research-reports\/common-comorbidities-substance-use-disorders\/what-are-treatments-c...."},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.35946\/arcr.v40.1.07","article-title":"Integrating treatment for co-occurring mental health conditions","volume":"40","author":"Yule AM","year":"2019","unstructured":"Yule AM, Kelly JF. Integrating treatment for co-occurring mental health conditions. Alcohol Res. 2019, 40:10.35946\/arcr.v40.1.07","journal-title":"Alcohol Res"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011723.pub2","article-title":"Mindfulness-based interventions for substance use disorders","volume":"10","author":"Goldberg SB","year":"2021","unstructured":"Goldberg SB, Pace B, Griskaitis M, et al.. Mindfulness-based interventions for substance use disorders. Cochrane Database Syst Rev. 2021, 10:CD011723. 10.1002\/14651858.CD011723.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000338","article-title":"Mindfulness-based relapse prevention for substance use disorders: a systematic review and meta-analysis","volume":"11","author":"Grant S","year":"2017","unstructured":"Grant S, Colaiaco B, Motala A, Shanman R, Booth M, Sorbero M, Hempel S. Mindfulness-based relapse prevention for substance use disorders: a systematic review and meta-analysis. J Addict Med. 2017, 11:386-96. 10.1097\/ADM.0000000000000338","journal-title":"J Addict Med"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.21r03223","article-title":"The growing epidemic of opioid use disorder in the elderly and its treatment: a review of the literature","volume":"25","author":"Konakanchi JS","year":"2023","unstructured":"Konakanchi JS, Sethi R. The growing epidemic of opioid use disorder in the elderly and its treatment: a review of the literature. Prim Care Companion CNS Disord. 2023, 25:10.4088\/PCC.21r03223","journal-title":"Prim Care Companion CNS Disord"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-021-00893-z","article-title":"Problematic opioid use among older adults: epidemiology, adverse outcomes and treatment considerations","volume":"38","author":"Dufort A","year":"2021","unstructured":"Dufort A, Samaan Z. Problematic opioid use among older adults: epidemiology, adverse outcomes and treatment considerations. Drugs Aging. 2021, 38:1043-53. 10.1007\/s40266-021-00893-z","journal-title":"Drugs Aging"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2017.04.005","article-title":"Why aren't physicians prescribing more buprenorphine?","volume":"78","author":"Huhn AS","year":"2017","unstructured":"Huhn AS, Dunn KE. Why aren't physicians prescribing more buprenorphine?. J Subst Abuse Treat. 2017, 78:1-7. 10.1016\/j.jsat.2017.04.005","journal-title":"J Subst Abuse Treat"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0953-z","article-title":"Treating chronic pain: an overview of clinical studies centered on the buprenorphine option","volume":"78","author":"Davis MP","year":"2018","unstructured":"Davis MP, Pasternak G, Behm B. Treating chronic pain: an overview of clinical studies centered on the buprenorphine option. Drugs. 2018, 78:1211-28. 10.1007\/s40265-018-0953-z","journal-title":"Drugs"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-6974-2_5","article-title":"Cardiovascular effects of methadone","author":"Leal MA","year":"2013","unstructured":"Leal MA, January CT. Cardiovascular effects of methadone. Handbook of Methadone Prescribing and Buprenorphine Therapy. Cruciani R, Knotkova H (ed): Springer, New York; 2013. 51-8. 10.1007\/978-1-4614-6974-2_5"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01764-9","article-title":"Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials","volume":"10","author":"Klimas J","year":"2021","unstructured":"Klimas J, Hamilton MA, Gorfinkel L, Adam A, Cullen W, Wood E. Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials. Syst Rev. 2021, 10:216. 10.1186\/s13643-021-01764-9","journal-title":"Syst Rev"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0266142","article-title":"Relative effectiveness of medications for opioid-related disorders: a systematic review and network meta-analysis of randomized controlled trials","volume":"17","author":"Lim J","year":"2022","unstructured":"Lim J, Farhat I, Douros A, Panagiotoglou D. Relative effectiveness of medications for opioid-related disorders: a systematic review and network meta-analysis of randomized controlled trials. PLoS One. 2022, 17:e0266142. 10.1371\/journal.pone.0266142","journal-title":"PLoS One"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-017-0143-4","article-title":"A cohort study examining emergency department visits and hospital admissions among people who use drugs in Ottawa, Canada","volume":"14","author":"Kendall CE","year":"2017","unstructured":"Kendall CE, Boucher LM, Mark AE, et al.. A cohort study examining emergency department visits and hospital admissions among people who use drugs in Ottawa, Canada. Harm Reduct J. 2017, 14:16. 10.1186\/s12954-017-0143-4","journal-title":"Harm Reduct J"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-020-00265-7","article-title":"Changes in quality of life and its associated factors among illicit drug users in Vietnamese mountainous provinces: a 12-month follow-up study","volume":"15","author":"Tran BX","year":"2020","unstructured":"Tran BX, Moir M, Nguyen TM, et al.. Changes in quality of life and its associated factors among illicit drug users in Vietnamese mountainous provinces: a 12-month follow-up study. Subst Abuse Treat Prev Policy. 2020, 15:23. 10.1186\/s13011-020-00265-7","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.osep.2024.05.003","article-title":"Alcohol use disorder in older adults: a review of recent literature on epidemiology, cognitive outcomes, and neuroimaging findings and treatment","volume":"1","author":"Steffens DC","year":"2024","unstructured":"Steffens DC, Wang L, Manning KJ, Holzhauer CG. Alcohol use disorder in older adults: a review of recent literature on epidemiology, cognitive outcomes, and neuroimaging findings and treatment. Am J Geriatr Psychiatry. 2024, 1:39-51. 10.1016\/j.osep.2024.05.003","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505409","article-title":"Extended-release naltrexone to prevent opioid relapse in criminal justice offenders","volume":"374","author":"Lee JD","year":"2016","unstructured":"Lee JD, Friedmann PD, Kinlock TW, et al.. Extended-release naltrexone to prevent opioid relapse in criminal justice offenders. N Engl J Med. 2016, 374:1232-42. 10.1056\/NEJMoa1505409","journal-title":"N Engl J Med"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2018.3537","article-title":"Anxiety, depression, and insomnia among adults with opioid dependence treated with extended-release naltrexone vs buprenorphine-naloxone: a randomized clinical trial and follow-up study","volume":"76","author":"Latif ZE","year":"2019","unstructured":"Latif ZE, \u0160altyte Benth J, Solli KK, et al.. Anxiety, depression, and insomnia among adults with opioid dependence treated with extended-release naltrexone vs buprenorphine-naloxone: a randomized clinical trial and follow-up study. JAMA Psychiatry. 2019, 76:127-34. 10.1001\/jamapsychiatry.2018.3537","journal-title":"JAMA Psychiatry"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-022-01346-z","article-title":"Telehealth-based delivery of medication-assisted treatment for opioid use disorder: a critical review of recent developments","volume":"24","author":"Mahmoud H","year":"2022","unstructured":"Mahmoud H, Naal H, Whaibeh E, Smith A. Telehealth-based delivery of medication-assisted treatment for opioid use disorder: a critical review of recent developments. Curr Psychiatry Rep. 2022, 24:375-86. 10.1007\/s11920-022-01346-z","journal-title":"Curr Psychiatry Rep"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1111\/add.15572","article-title":"Effect of extended-release naltrexone on alcohol consumption: a systematic review and meta-analysis","volume":"117","author":"Murphy CE 4th","year":"2022","unstructured":"Murphy CE 4th, Wang RC, Montoy JC, Whittaker E, Raven M. Effect of extended-release naltrexone on alcohol consumption: a systematic review and meta-analysis. Addiction. 2022, 117:271-81. 10.1111\/add.15572","journal-title":"Addiction"},{"key":"ref68","unstructured":"Disulfiram. (2023). Accessed. 24 June 2024: https:\/\/www.royalfree.nhs.uk\/patients-and-visitors\/patient-information-leaflets\/disulfiram-antabuse#:~:text=It%20will...."},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-031323-115847","article-title":"Alcohol use disorder treatment: problems and solutions","volume":"64","author":"Koob GF","year":"2024","unstructured":"Koob GF. Alcohol use disorder treatment: problems and solutions. Annu Rev Pharmacol Toxicol. 2024, 64:255-75. 10.1146\/annurev-pharmtox-031323-115847","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agt053","article-title":"Combining medical treatment and CBT in treating alcohol-dependent patients: effects on life quality and general well-being","volume":"48","author":"Laaksonen E","year":"2013","unstructured":"Laaksonen E, Vuoristo-Myllys S, Koski-Jannes A, Alho H. Combining medical treatment and CBT in treating alcohol-dependent patients: effects on life quality and general well-being. Alcohol Alcohol. 2013, 48:687-93. 10.1093\/alcalc\/agt053","journal-title":"Alcohol Alcohol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1093\/alcalc\/agq001","article-title":"Supervised disulfiram in relapse prevention in alcohol-dependent patients suffering from comorbid borderline personality disorder--a case series","volume":"45","author":"Mutschler J","year":"2010","unstructured":"Mutschler J, Grosshans M, Koopmann A, Hermann D, Diehl A, Mann K, Kiefer F. Supervised disulfiram in relapse prevention in alcohol-dependent patients suffering from comorbid borderline personality disorder--a case series. Alcohol Alcohol. 2010, 45:146-50. 10.1093\/alcalc\/agq001","journal-title":"Alcohol Alcohol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14030294","article-title":"A narrative review of current and emerging trends in the treatment of alcohol use disorder","volume":"14","author":"Celik M","year":"2024","unstructured":"Celik M, Gold MS, Fuehrlein B. A narrative review of current and emerging trends in the treatment of alcohol use disorder. Brain Sci. 2024, 14:10.3390\/brainsci14030294","journal-title":"Brain Sci"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0423-9","article-title":"Acamprosate: a review of its use in alcohol dependence","volume":"75","author":"Plosker GL","year":"2015","unstructured":"Plosker GL. Acamprosate: a review of its use in alcohol dependence. Drugs. 2015, 75:1255-68. 10.1007\/s40265-015-0423-9","journal-title":"Drugs"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200219080-00004","article-title":"Relapse prevention and maintaining abstinence in older adults with alcohol-use disorders","volume":"19","author":"Barrick C","year":"2002","unstructured":"Barrick C, Connors GJ. Relapse prevention and maintaining abstinence in older adults with alcohol-use disorders. Drugs Aging. 2002, 19:583-94. 10.2165\/00002512-200219080-00004","journal-title":"Drugs Aging"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000146.pub4","article-title":"Nicotine replacement therapy for smoking cessation","volume":"11","author":"Stead LF","year":"2012","unstructured":"Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012, 11:CD000146. 10.1002\/14651858.CD000146.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9090","article-title":"Effects of aging on the effectiveness of smoking cessation medication","volume":"7","author":"Scholz J","year":"2016","unstructured":"Scholz J, Santos PC, Buzo CG, et al.. Effects of aging on the effectiveness of smoking cessation medication. Oncotarget. 2016, 7:30032-6. 10.18632\/oncotarget.9090","journal-title":"Oncotarget"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-55711-8_16","article-title":"Nicotine use disorder","author":"Khan A","year":"2024","unstructured":"Khan A, Tampi RR, Tampi DJ. Nicotine use disorder. Treatment of Psychiatric Disorders Among Older Adults. Tampi RR, Tampi DJ (ed): Springer, Cham; 2024. 227-39. 10.1007\/978-3-031-55711-8_16"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.2147\/copd.s1121","article-title":"The use of bupropion SR in cigarette smoking cessation","volume":"3","author":"Wilkes S","year":"2008","unstructured":"Wilkes S. The use of bupropion SR in cigarette smoking cessation. Int J Chron Obstruct Pulmon Dis. 2008, 3:45-53. 10.2147\/copd.s1121","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000031.pub5","article-title":"Antidepressants for smoking cessation","volume":"4","author":"Howes S","year":"2020","unstructured":"Howes S, Hartmann-Boyce J, Livingstone-Banks J, Hong B, Lindson N. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2020, 4:CD000031. 10.1002\/14651858.CD000031.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref80","article-title":"Smoking cessation in the elderly","volume":"15","author":"Elhassan A","year":"2007","unstructured":"Elhassan A, Chow RD . Smoking cessation in the elderly. Clin Geriatr. 2007, 15:38.","journal-title":"Clin Geriatr"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntac138","article-title":"Evaluating treatment mechanisms of varenicline: mediation by affect and craving","volume":"24","author":"Tonkin SS","year":"2022","unstructured":"Tonkin SS, Colder C, Mahoney MC, et al.. Evaluating treatment mechanisms of varenicline: mediation by affect and craving. Nicotine Tob Res. 2022, 24:1803-10. 10.1093\/ntr\/ntac138","journal-title":"Nicotine Tob Res"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16183462","article-title":"Factors correlated with smoking cessation success in older adults: a retrospective cohort study in Taiwan","volume":"16","author":"Chang CP","year":"2019","unstructured":"Chang CP, Huang WH, You CH, Hwang LC, Lu IJ, Chan HL. Factors correlated with smoking cessation success in older adults: a retrospective cohort study in Taiwan. Int J Environ Res Public Health. 2019, 16:10.3390\/ijerph16183462","journal-title":"Int J Environ Res Public Health"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntx275","article-title":"Comparative effectiveness of varenicline and nicotine replacement therapy for smoking cessation in older and younger smokers: a prospective cohort in Taiwan","volume":"21","author":"Chang PY","year":"2019","unstructured":"Chang PY, Shiu MN, Yuan YT, Chang HC, Su PY, Lan TH. Comparative effectiveness of varenicline and nicotine replacement therapy for smoking cessation in older and younger smokers: a prospective cohort in Taiwan. Nicotine Tob Res. 2019, 21:149-55. 10.1093\/ntr\/ntx275","journal-title":"Nicotine Tob Res"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231095","article-title":"Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): a randomized controlled clinical trial","volume":"15","author":"Carson-Chahhoud KV","year":"2020","unstructured":"Carson-Chahhoud KV, Smith BJ, Peters MJ, et al.. Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): a randomized controlled clinical trial. PLoS One. 2020, 15:e0231095. 10.1371\/journal.pone.0231095","journal-title":"PLoS One"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1111\/add.14951","article-title":"Cardiovascular and neuropsychiatric safety of smoking cessation pharmacotherapies in non-depressed adults: a retrospective cohort study","volume":"115","author":"Carney G","year":"2020","unstructured":"Carney G, Bassett K, Maclure M, Taylor S, Dormuth CR. Cardiovascular and neuropsychiatric safety of smoking cessation pharmacotherapies in non-depressed adults: a retrospective cohort study. Addiction. 2020, 115:1534-46. 10.1111\/add.14951","journal-title":"Addiction"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.32214","article-title":"Adaptive smoking cessation using precessation varenicline or nicotine patch: a randomized clinical trial","volume":"6","author":"Davis JM","year":"2023","unstructured":"Davis JM, Masclans L, Rose JE. Adaptive smoking cessation using precessation varenicline or nicotine patch: a randomized clinical trial. JAMA Netw Open. 2023, 6:e2332214. 10.1001\/jamanetworkopen.2023.32214","journal-title":"JAMA Netw Open"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntw283","article-title":"Combination varenicline\/bupropion treatment benefits highly dependent smokers in an adaptive smoking cessation paradigm","volume":"19","author":"Rose JE","year":"2017","unstructured":"Rose JE, Behm FM. Combination varenicline\/bupropion treatment benefits highly dependent smokers in an adaptive smoking cessation paradigm. Nicotine Tob Res. 2017, 19:999-1002. 10.1093\/ntr\/ntw283","journal-title":"Nicotine Tob Res"},{"key":"ref88","unstructured":"Cognitive-behavioral therapy (CBT) techniques in addiction recovery. (2024). Accessed. 28 June 2024: https:\/\/www.brightertomorrowtherapy.com\/blog\/cognitive-behavioral-therapy-cbt-techniques-in-addiction-recovery."},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S375653","article-title":"Prevalence and treatment of substance misuse in older adults: beyond early adulthood","volume":"15","author":"Hu J","year":"2024","unstructured":"Hu J, Kulkarni N, Maliha P, Grossberg G. Prevalence and treatment of substance misuse in older adults: beyond early adulthood. Subst Abuse Rehabil. 2024, 15:87-98. 10.2147\/SAR.S375653","journal-title":"Subst Abuse Rehabil"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1192\/apt.bp.106.003020","article-title":"Cognitive-behavioural therapy with older people","volume":"13","author":"Evans C","year":"2007","unstructured":"Evans C. Cognitive-behavioural therapy with older people. Adv Psychiatr Treat. 2007, 13:111-8. 10.1192\/apt.bp.106.003020","journal-title":"Adv Psychiatr Treat"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.9873","article-title":"Feasibility and effects of digital interventions to support people in recovery from substance use disorders: systematic review","volume":"20","author":"Nesv\u00e5g S","year":"2018","unstructured":"Nesv\u00e5g S, McKay JR. Feasibility and effects of digital interventions to support people in recovery from substance use disorders: systematic review. J Med Internet Res. 2018, 20:e255. 10.2196\/jmir.9873","journal-title":"J Med Internet Res"},{"key":"ref92","unstructured":"Enhancing motivation for change in substance use disorder treatment. (2019). Accessed. 28 June 2024: https:\/\/store.samhsa.gov\/sites\/default\/files\/tip-35-pep19-02-01-003.pdf."},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2022.12.232","article-title":"Infusing the\" motivation\" into motivational interviewing: addressing unique challenges in older adults with substance use disorders","volume":"31","author":"Cummings N","year":"2023","unstructured":"Cummings N, Lantz M, GomezAbreu N, Sidor M. Infusing the\" motivation\" into motivational interviewing: addressing unique challenges in older adults with substance use disorders. Am J Geriatr Psychiatry. 2023, 31:S70-S71. 10.1016\/j.jagp.2022.12.232","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1037\/ccp0000096","article-title":"A randomized clinical trial of Motivational Interviewing to reduce alcohol and drug use among patients with depression","volume":"84","author":"Satre DD","year":"2016","unstructured":"Satre DD, Leibowitz A, Sterling SA, Lu Y, Travis A, Weisner C. A randomized clinical trial of Motivational Interviewing to reduce alcohol and drug use among patients with depression. J Consult Clin Psychol. 2016, 84:571-9. 10.1037\/ccp0000096","journal-title":"J Consult Clin Psychol"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.03.004","article-title":"Is fidelity to motivational interviewing associated with alcohol outcomes in treatment-seeking 60+ year-old citizens?","volume":"101","author":"Kramer Schmidt L","year":"2019","unstructured":"Kramer Schmidt L, Moyers TB, Nielsen AS, Andersen K. Is fidelity to motivational interviewing associated with alcohol outcomes in treatment-seeking 60+ year-old citizens?. J Subst Abuse Treat. 2019, 101:1-11. 10.1016\/j.jsat.2019.03.004","journal-title":"J Subst Abuse Treat"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1111\/acer.15015","article-title":"Age as a moderator of motivational interviewing and nondirective client-centered psychotherapy for alcohol use disorder: an exploratory study","volume":"47","author":"Kuerbis A","year":"2023","unstructured":"Kuerbis A, Behrendt S, Morgenstern J. Age as a moderator of motivational interviewing and nondirective client-centered psychotherapy for alcohol use disorder: an exploratory study. Alcohol Clin Exp Res (Hoboken). 2023, 47:527-39. 10.1111\/acer.15015","journal-title":"Alcohol Clin Exp Res (Hoboken)"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004307.pub5","article-title":"Incentives for smoking cessation","author":"Cahill K","year":"2015","unstructured":"Cahill K, Hartmann-Boyce J, Perera R. Incentives for smoking cessation. Cochrane Database Syst Rev. 2015, CD004307. 10.1002\/14651858.CD004307.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1037\/adb0000287","article-title":"Contingency management treatment for substance use disorders: how far has it come, and where does it need to go?","volume":"31","author":"Petry NM","year":"2017","unstructured":"Petry NM, Alessi SM, Olmstead TA, Rash CJ, Zajac K. Contingency management treatment for substance use disorders: how far has it come, and where does it need to go?. Psychol Addict Behav. 2017, 31:897-906. 10.1037\/adb0000287","journal-title":"Psychol Addict Behav"},{"key":"ref99","unstructured":"Principles of drug addiction treatment. a research-based guide (third edition). (2014). Accessed: 30 June 2024: https:\/\/nida.nih.gov\/sites\/default\/files\/podat-3rdEd-508.pdf#:~:text=URL%3A%20https%3A%2F%2Fnida.nih.gov%2Fsites%2Fde...."},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-021-00371-0","article-title":"A review of research-supported group treatments for drug use disorders","volume":"16","author":"L\u00f3pez G","year":"2021","unstructured":"L\u00f3pez G, Orchowski LM, Reddy MK, Nargiso J, Johnson JE. A review of research-supported group treatments for drug use disorders. Subst Abuse Treat Prev Policy. 2021, 16:51. 10.1186\/s13011-021-00371-0","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.03.012","article-title":"Motivationally enhanced group counseling for substance users in a soup kitchen: a randomized clinical trial","volume":"80","author":"Rosenblum A","year":"2005","unstructured":"Rosenblum A, Magura S, Kayman DJ, Fong C. Motivationally enhanced group counseling for substance users in a soup kitchen: a randomized clinical trial. Drug Alcohol Depend. 2005, 80:91-103. 10.1016\/j.drugalcdep.2005.03.012","journal-title":"Drug Alcohol Depend"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.01.016","article-title":"Group treatment for substance use disorder in adults: a systematic review and meta-analysis of randomized-controlled trials","volume":"99","author":"Lo Coco G","year":"2019","unstructured":"Lo Coco G, Melchiori F, Oieni V, et al.. Group treatment for substance use disorder in adults: a systematic review and meta-analysis of randomized-controlled trials. J Subst Abuse Treat. 2019, 99:104-16. 10.1016\/j.jsat.2019.01.016","journal-title":"J Subst Abuse Treat"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1080\/10673220490905723","article-title":"Group therapy for substance use disorders: what do we know?","volume":"12","author":"Weiss RD","year":"2004","unstructured":"Weiss RD, Jaffee WB, de Menil VP, Cogley CB. Group therapy for substance use disorders: what do we know?. Harv Rev Psychiatry. 2004, 12:339-50. 10.1080\/10673220490905723","journal-title":"Harv Rev Psychiatry"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1111\/jmft.12546","article-title":"Couple and family therapy for substance use disorders: evidence-based update 2010-2019","volume":"48","author":"Hogue A","year":"2022","unstructured":"Hogue A, Schumm JA, MacLean A, Bobek M. Couple and family therapy for substance use disorders: evidence-based update 2010-2019. J Marital Fam Ther. 2022, 48:178-203. 10.1111\/jmft.12546","journal-title":"J Marital Fam Ther"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1111\/j.1752-0606.2011.00280.x","article-title":"Family therapy for drug abuse: review and updates 2003-2010","volume":"38","author":"Rowe CL","year":"2012","unstructured":"Rowe CL. Family therapy for drug abuse: review and updates 2003-2010. J Marital Fam Ther. 2012, 38:59-81. 10.1111\/j.1752-0606.2011.00280.x","journal-title":"J Marital Fam Ther"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2011.09.010","article-title":"Treatment of substance abusing patients with comorbid psychiatric disorders","volume":"37","author":"Kelly TM","year":"2012","unstructured":"Kelly TM, Daley DC, Douaihy AB. Treatment of substance abusing patients with comorbid psychiatric disorders. Addict Behav. 2012, 37:11-24. 10.1016\/j.addbeh.2011.09.010","journal-title":"Addict Behav"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1080\/19371918.2013.758975","article-title":"Treatment for substance use disorder: opportunities and challenges under the affordable care act","volume":"28","author":"Tai B","year":"2013","unstructured":"Tai B, Volkow ND. Treatment for substance use disorder: opportunities and challenges under the affordable care act. Soc Work Public Health. 2013, 28:165-74. 10.1080\/19371918.2013.758975","journal-title":"Soc Work Public Health"},{"key":"ref108","unstructured":"Integrating substance use disorder treatment and primary care. (2017). Accessed. 30 June 2024: https:\/\/eadn-wc03-6094147.nxedge.io\/cdn\/wp-content\/uploads\/2017\/02\/Primary-Care-Integration-Brief.pdf."},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-03083469-2","article-title":"Integrated care approach to the prevention of opioid use disorder","author":"Schainker LM","year":"2021","unstructured":"Schainker LM, Voss MW, Yaugher AC. Integrated care approach to the prevention of opioid use disorder. Handbook of Evidence-Based Prevention of Behavioral Disorders in Integrated Care. O'Donohue W, Zimmermann M (ed): Springer, Cham; 2021. 267-89. 10.1007\/978-3-03083469-2"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/285821-the-nexus-of-aging-and-substance-use-a-scoping-review-of-therapeutic-modalities-for-geriatric-substance-use-disorders","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T07:30:14Z","timestamp":1727422214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/285821-the-nexus-of-aging-and-substance-use-a-scoping-review-of-therapeutic-modalities-for-geriatric-substance-use-disorders"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":109,"URL":"https:\/\/doi.org\/10.7759\/cureus.70313","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,27]]}}}